Xianning Zhang
Overview
Explore the profile of Xianning Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Nie C, Sun F, Jiang X, Zhang X, Fu J, et al.
ACS Appl Mater Interfaces
. 2024 Apr;
16(17):22632-22640.
PMID: 38642041
Dirac semimetals have demonstrated significant attraction in the field of optoelectronics due to their unique bandgap structure and high carrier mobility. Combining them with classical semiconductor materials to form heterojunctions...
2.
Zhang X, Liu L, Wang J, Yao M, Liu L, Liu H, et al.
Tissue Cell
. 2023 Dec;
86:102287.
PMID: 38086146
Background: Increasing evidence indicate that enhanced adipogenic differentiation of bone marrow mesenchymal stem cells (BM-MSCs) could contribute to the adiposity alteration in marrow microenvironment of aplastic anemia (AA). Identifying small...
3.
Yang D, Sun B, Li S, Wei W, Liu X, Cui X, et al.
Sci Transl Med
. 2023 Aug;
15(709):eadd1951.
PMID: 37585504
Cellular senescence, characterized by stable cell cycle arrest, plays an important role in aging and age-associated pathologies. Eliminating senescent cells rejuvenates aged tissues and ameliorates age-associated diseases. Here, we identified...
4.
Liu L, Liu H, Liu L, Huang Q, Yang C, Cheng P, et al.
Cancer Biol Ther
. 2023 Jun;
24(1):2228497.
PMID: 37381175
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by abnormal cell proliferation, apoptosis repression and myeloid differentiation blockade of hematopoietic stem/progenitor cells. Developing and identifying novel therapeutic agents...
5.
Zhang X, Liu L, Liu X, Huang Q, Liu L, Liu H, et al.
iScience
. 2023 Mar;
26(3):106221.
PMID: 36879811
Increased propensity of bone marrow-derived mesenchymal stem cells (BM-MSCs) toward adipogenic differentiation at the expense of osteogenesis has been implicated in obesity, diabetes, and age-related osteoporosis as well as various...
6.
Zheng X, Lv X, Chai J, Huang Y, Zhu L, Zhang X
Mol Med Rep
. 2022 Sep;
26(5).
PMID: 36177918
Increasing evidence suggests that core circadian genes have major roles in the carcinogenic mechanisms of multiple human malignancies. Among these genes, the role of reticulon 2 (RTN2) in ovarian cancer...
7.
Zhang J, Chen K, Tang Y, Luan X, Zheng X, Lu X, et al.
Cell Death Dis
. 2021 Apr;
12(4):367.
PMID: 33824300
Gastrointestinal stromal tumors (GISTs) are common neoplasms of the gastrointestinal tract that can be treated successfully using C-kit target therapy and surgery; however, imatinib chemoresistance is a major barrier to...
8.
Tang Y, Chen K, Luan X, Zhang J, Liu R, Zheng X, et al.
Int J Oncol
. 2020 Nov;
57(6):1368-1380.
PMID: 33174013
Hepatocellular carcinoma (HCC) is an invasive malignant neoplasm with a poor prognosis. The development of chemoresistance severely obstructs the chemotherapeutic efficiency of HCC treatment. Therefore, understanding the mechanisms of chemoresistance...
9.
Liu L, Zhang J, Zhang X, Cheng P, Liu L, Huang Q, et al.
J Mol Med (Berl)
. 2020 Oct;
99(1):107-118.
PMID: 33128580
High mobility group box 1 (HMGB1) is a non-histone nuclear protein which has been intensively studied in various physiological and pathological processes including leukemia. Here in this study, we further...
10.
Kabir S, Dai Z, Nurujjaman M, Cui X, Asaduzzaman A, Sun B, et al.
J Cell Mol Med
. 2020 Oct;
24(22):13223-13234.
PMID: 33047886
The importance of biogenic silver/silver chloride nanoparticles has become increasing day by day. In the present study, silver/silver chloride nanoparticles (Ag/AgCl-NPs) were synthesized from Kaempferia rotunda tuberous rhizome extract to...